Haemophilus	B:C0917807
influenzae	I:C0917807
type	I:C0917807
b	I:C0917807
meningitis	I:C0917807
in	O
a	O
vaccinated	B:C0042196
and	O
immunocompetent	B:C1512656
child	O
.	O

Invasive	B:C4302339
Haemophilus	I:C4302339
influenzae	I:C4302339
type	I:C4302339
b	I:C4302339
(	I:C4302339
Hib	I:C4302339
)	I:C4302339
disease	I:C4302339
decreased	O
dramatically	O
after	O
the	O
introduction	O
of	O
conjugate	B:C0206515
vaccine	I:C0206515
in	O
routine	O
immunization	B:C0020972
schedules	I:C0020972
.	O

We	O
report	B:C0085973
a	O
case	O
of	O
a	O
fifteen	O
-	O
months	O
-	O
old	O
girl	O
,	O
previously	O
healthy	O
and	O
vaccinated	B:C0042196
,	O
admitted	B:C0184666
in	O
the	O
emergency	B:C0562508
room	I:C0562508
with	O
fever	B:C0015967
and	O
vomiting	B:C0042963
.	O

She	O
was	O
irritable	B:C0022107
and	O
the	O
Brudzinski's	B:C0234179
sign	I:C0234179
was	O
positive	B:C0238854
.	O

The	O
cerebrospinal	B:C0007806
fluid	I:C0007806
(	O
cerebrospinal	B:C0007806
fluid	I:C0007806
)	O
analysis	O
showed	O
pleocytosis	B:C0151857
and	O
high	B:C0428479
protein	I:C0428479
level	I:C0428479
.	O

Empiric	O
intravenous	B:C0348016
antibiotics	B:C0003232
(	O
ceftriaxone	B:C0007561
and	O
vancomycin	B:C0042313
)	O
were	O
administered	O
for	O
suspected	O
bacterial	B:C0085437
meningitis	I:C0085437
during	O
10	O
days	O
.	O

Serotyping	B:C0201217
of	O
the	O
Haemophilus	B:C0018483
influenzae	I:C0018483
strain	I:C0018483
found	O
in	O
cerebrospinal	B:C0007806
fluid	I:C0007806
revealed	O
a	O
serotype	B:C0456771
b.	I:C0456771

After	O
one	O
year	O
of	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
no	B:C0497153
Hib	I:C0497153
meningitis	I:C0497153
sequelae	O
were	O
noted	O
.	O

Despite	O
vaccination	B:C0042196
compliance	B:C3714738
and	O
absence	O
of	O
risk	B:C0035648
factors	I:C0035648
,	O
invasive	B:C4302339
Hib	I:C4302339
disease	I:C4302339
can	O
occur	O
due	O
to	O
vaccine	B:C0042210
failure	O
.	O

Efforts	O
to	O
keep	O
the	O
low	O
incidence	O
of	O
invasive	B:C4302339
Hib	I:C4302339
disease	I:C4302339
should	O
be	O
directed	O
to	O
the	O
maintenance	O
of	O
high	O
vaccination	B:C0042196
coverage	O
rates	O
,	O
combined	O
with	O
the	O
notification	B:C0422202
and	O
surveillance	B:C0038842
strategies	I:C0038842
already	O
implemented	O
in	O
each	O
country	B:C0454664
.	O

